High-Intensity Treatment Plans and the CMS ABA Toolkit
The autism therapy industry will likely have to justify itself at every turn when it comes to hour-intensive treatment plans as states digest the Applied Behavior Analysis (ABA) Toolkit released by the Centers for Medicare and Medicaid Services (CMS) in August.
The 173-page toolkit offers insights into CMS’ perspective on best practices for delivering ABA, its oversight, and reimbursement. It serves as a roadmap for states to balance access to personalized treatment, cost management, and fraud prevention in Medicaid.
Personalized Treatment Plans
The toolkit emphasizes the importance of individualized treatment plans, stating that every patient requires a personalized plan that is updated regularly to reflect treatment progress. This suggests a shift away from generic, high-hour treatment plans.
Potential Fraud Concerns
While the toolkit does not impose regulations, it raises concerns that consistently using standard, high-intensity treatment plans might be flagged as potential fraud.
State-by-State Impact
Without a direct rule or regulation, the toolkit's impact will vary among states. Each state will interpret and implement its guidance in its own way.
Recognizing ABA as Mainstream
The toolkit reinforces ABA as the standard treatment for autism, especially in early intervention settings. It also acknowledges other behavioral and developmental models as valid alternatives.
Regulatory Focus
Notably, the toolkit devotes significant space to outlining best practices and guidelines for regulating ABA, underscoring the need for continuous compliance and fraud prevention.
Advocates of care delivery models that differ from center-based, clinician-directed therapy may view the toolkit as a victory, as it does not endorse ABA as the sole treatment for autism.